CALOMIST Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Calomist, and what generic alternatives are available?
Calomist is a drug marketed by Par Pharm and is included in one NDA.
The generic ingredient in CALOMIST is cyanocobalamin. There are nine drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the cyanocobalamin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Calomist
A generic version of CALOMIST was approved as cyanocobalamin by PADAGIS ISRAEL on September 9th, 2020.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CALOMIST?
- What are the global sales for CALOMIST?
- What is Average Wholesale Price for CALOMIST?
Summary for CALOMIST
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
DailyMed Link: | CALOMIST at DailyMed |
US Patents and Regulatory Information for CALOMIST
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Par Pharm | CALOMIST | cyanocobalamin | SPRAY, METERED;NASAL | 022102-001 | Jul 27, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |